Conantokin-G: a novel peptide antagonist to the N-methyl-D-aspartic acid (NMDA) receptor

Neurosci Lett. 1990 Oct 16;118(2):241-4. doi: 10.1016/0304-3940(90)90637-o.

Abstract

Conantokin-G is a 17 amino acid peptide isolated from the venom of the fish-eating snail Conus geographus which produces hyperactivity when injected into the brains of adult mice. We show that this peptide is a selective N-methyl-D-aspartate (NMDA) antagonist based on its ability to block NMDA-induced elevation of cGMP in rat cerebellar slices in vitro (IC50 = 171 nM), but not kainic acid-induced elevations. This inhibition could not be overcome by increasing the NMDA concentration, indicating non-competitive inhibition. Conantokin-G displayed no affinity for binding sites for thienylcyclohexylpiperidine, various glutamate subclasses or those for several other neurotransmitters/neuromodulators. This peptide, however, enhanced [3H]glycine binding to rat forebrain membranes but not to spinal cord membranes. The activity profile of the peptide in various assays indicates that it is a novel type of non-competitive NMDA antagonist.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Conotoxins*
  • Cyclic GMP / metabolism
  • Glutamates / metabolism
  • Glycine / metabolism
  • In Vitro Techniques
  • Kainic Acid / pharmacology
  • Molecular Sequence Data
  • N-Methylaspartate / antagonists & inhibitors
  • Peptides, Cyclic / pharmacology*
  • Phencyclidine / analogs & derivatives
  • Phencyclidine / metabolism
  • Rats
  • Receptors, N-Methyl-D-Aspartate / antagonists & inhibitors*
  • Tritium

Substances

  • Conotoxins
  • Glutamates
  • Peptides, Cyclic
  • Receptors, N-Methyl-D-Aspartate
  • Tritium
  • N-Methylaspartate
  • tenocyclidine
  • conotoxin GV
  • Cyclic GMP
  • Phencyclidine
  • Kainic Acid
  • Glycine